Leveraging Transcriptional Readouts as a Platform for Drug Repurposing in Cardiomyopathy

Circulation. 2025 May 20;151(20):1449-1450. doi: 10.1161/CIRCULATIONAHA.125.074556. Epub 2025 May 19.

Authors

Ahmed I Mahmoud¹, Hesham A Sadek^{2

3

4}

Affiliations

¹ Center for Cardiovascular and Muscular Diseases, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA (A.I.M.).
² Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain (H.A.S.).
³ Division of Cardiology, University of Arizona College of Medicine, Tucson (H.A.S.).
⁴ University of Arizona Sarver Heart Center, Tucson (H.A.S.).

PMID: 40388510
PMCID: PMC12092052 (available on 2026-05-20)
DOI: 10.1161/CIRCULATIONAHA.125.074556

No abstract available

Keywords: Editorials; cardiomyopathies; gene expression.

Publication types

Editorial
Comment

Grants and funding